Press releases

Ladenburg, 04 May 2015

TCC TB: Jungbunzlauer’s novel excipient for direct tablet compression

TCC TB is Jungbunzlauer’s name for tricalcium citrate tetrahydrate which was designed to function as an excipient. TCC TB combines exceptional compression characteristics, excellent flowability and good tolerability, making it the ideal choice for a direct compression excipient.

Direct compression is considered to be the most economic process in tablet manufacturing in terms of labour, time, equipment, operational energy, and space. This production method eliminates problems due to heat and moisture that occur during wet granulation, but it also demands exceptional properties of active ingredients and excipients. TCC TB is a highly pure granular powder with a special crystalline structure that allows the production of tablets of high tensile strength already at low compression forces.  Tablets produced with TCC TB have a low relative density which facilitates the rapid disintegration even of very hard tablets.

Compliant with the latest versions of the United States Pharmacopeia (USP) and the Food Chemicals Codex (FCC), TCC TB can be used in a wide range of tableting applications. It is produced in our manufacturing site in Ladenburg, Germany in a unique process resulting in its outstanding characteristics.


Find out more about Jungbunzlauer’s TCC TB:
http://www.nutraceuticalsworld.com/contents/view_white-papers-tech-papers/2015-04-23/tcc-tb---novel-excipient-for-direct-compression/

For questions please contact: headquartersjungbunzlauer.com